Microbot Medical Inc (MBOT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$1.440.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · MBOT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
MBOT — CFO transition
Dated 2026-08-07
Chief Financial Officer — Rachel Vaknin: Salary increase for the Chief Financial Officer.
Why it matters: Getting a CE Mark allows entry into global markets. This can lead to more growth.
Supportive ifThe company announces receipt of CE Mark for the LIBERTY System.
Worry ifThere may be delays in the CE Mark process or negative feedback from regulators.
Why it matters: Progress on the government funding agreement could boost sales for the LIBERTY system. This would show demand and support growth.
Supportive ifA press release says the LIBERTY system was sold to 500 government facilities.
Worry ifThere are no sales announcements or delays in the government funding deal.
Why it matters: More sales territories mean a bigger market presence and more chances to make money.
Supportive ifThe company will add new sales territories to reach 12 by December 2026.
Worry ifThe company stays at 8 sales territories with no new additions by year-end.
Why it matters: Strong revenue growth shows that the LIBERTY System is being used and is in demand.
Supportive ifQ3 revenue growth exceeds 100% compared to Q3 2025.
Worry ifQ3 revenue growth falls below 50% year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$168 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $736 loss on $10,000 · 7.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,800 loss on $10,000 · 68.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Success in this partnership could boost sales at U.S. government facilities.
Supportive ifThere is news of first sales or contracts from the Lovell agreement.
Worry ifNo sales or contracts reported from the Lovell agreement within six months.
Why it matters: Updates on the ATM program could signal how well the company is raising capital. This affects financial stability.
Watch forManagement says they raised over $5 million through the ATM program.
Also watch forManagement says there are challenges in raising capital through the ATM program.
Why it matters: A second manufacturing site will help meet demand and raise profits for the LIBERTY System.
Supportive ifThe second manufacturing site starts working to meet demand.
Worry ifNo progress on the second manufacturing site by the end of the year.
Why it matters: Entering new countries can boost revenue. It also helps raise brand awareness.
Supportive ifThe company will enter international markets by the end of 2026.
Worry ifCompany does not enter any international markets by the end of the year.
Why it matters: A second manufacturing site will help make more products. It may also raise profits.
Supportive ifThe second manufacturing site will start production by Q4 2026.
Worry ifNo progress on the second manufacturing site by year-end.
Why it matters: More procedures mean customers are happy and using the system more.
Supportive ifProcedure volume goes up quarter over quarter in Q3 2026.
Worry ifProcedure volume declines or remains flat in Q3 2026.
Why it matters: If federal healthcare systems adopt it, LIBERTY System sales can rise a lot.
Supportive ifFederal healthcare systems are giving new contracts or orders. They use the LIBERTY System.
Worry ifNo new contracts or orders from federal healthcare systems in the next quarter.